Why does Heron suck?

Discussion in 'Heron Therapeutics' started by anonymous, Oct 4, 2019 at 1:29 PM.

Tags: Add Tags
  1. anonymous

    anonymous Guest

    Interesting way to look at it. Balance sheet watchers should stand up and ask some tough questions, are these people really needed?
     

  2. anonymous

    anonymous Guest

    Be glad you are not working for BMS, AZ, Merck....etc. they’ll downsize by xmas
     
  3. anonymous

    anonymous Guest

    hey oracle, thanks. Working for half the money anyways, don’t forget all the worthless options deposited in your account month after month. Economy is opening up, perfect time to jump the ship for many.
     
  4. anonymous

    anonymous Guest

    Yeah....lots of pharma hiring right now. About to launch a supposedly major drug and not hiring the sales force. That’s the reality of our environment. Check that emergency fund.
     
  5. anonymous

    anonymous Guest

    Is there anyone from company with half a brain on this board or just sales reps? Only question is are you going to get approval and good label or are you dopes going to get YET ANOTHER CRL?

    Assuming you do get approval, does your commercial leadership have a clue on how to launch this? Right now, the street says no.
     
  6. anonymous

    anonymous Guest

    Press release on knee study, what a joke! Apparently the study design aimed very low on the setting of endpoints based on the percentages in the results. No one will be impressed with this.
     
  7. anonymous

    anonymous Guest

    Get your lube ready people, it’s coming.
     
  8. anonymous

    anonymous Guest

    Anyone feeling a little nervous? One week away!
    Things seem too quiet.
     
  9. anonymous

    anonymous Guest

    Yes
     
  10. anonymous

    anonymous Guest

    if you follow the fda pdufa calender dates you will see the fda has issued a delay notice for almost ever June pdufa of up to 90 days in order to complete reviews.
    Fda issues the delay within 0-5 days of each pdufa date. Find out out this week either way.
     
  11. anonymous

    anonymous Guest

    They already issued a 90 day delay back in March.
     
  12. anonymous

    anonymous Guest

    i know. Question was people worried about another one. We will know within72
    Hours so that’s good.
     
  13. anonymous

    anonymous Guest

    So what does the industry’s worst CMC team have in store for us this year? Should we even bother hiring reps to sell this drug?
     
  14. anonymous

    anonymous Guest

    I just got an offer
     
  15. anonymous

    anonymous Guest

    Start date? Options?
     
  16. anonymous

    anonymous Guest

    PCRX above 70/share, interesting
     
  17. anonymous

    anonymous Guest

    Pacira has no fear of this company because your management is incompetent and will blow the launch IF you ever get it approved. Thank God I don’t work there!
     
  18. anonymous

    anonymous Guest

    Seriously one of the worst companies in biopharm. How hard can it be to get a 505 b2 submission approved YEARS after getting great data? Absolute clown show.
     
  19. anonymous

    anonymous Guest

    There is a definite lack of accountability here. Has anyone ever been fired or is it just Commercial folks leaving on their own because they see the writing on the wall?
     
  20. anonymous

    anonymous Guest

    Zero leadership accountability, just more bonuses and stock options for the clowns that keep failing. Quite sure BQ wants to sell this POS if he ever gets the chance. Will make tens of millions despite having the worst approval record in the industry.